| Completed |
: Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
: - Fallopian Tube Cancer
- Ovarian Cancer
- Peritoneal Cavity Can
: 2005-09-20
: - Drug: gemcitabine hydrochloride
- Drug: topo
|
| Completed |
: Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
: - Fallopian Tube Cancer
- Ovarian Cancer
- Peritoneal Cavity Can
: 2005-09-20
: - Biological: pegfilgrastim
- Drug: carboplati
|
| Completed |
: An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
: - Genital Neoplasms, Female
- Fallopian Tube Neoplasms
- Ovarian
: 2005-09-12
:
|
| Completed |
: A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.
: - Genital Neoplasms, Female
- Fallopian Tube Neoplasms
- Ovarian
: 2005-09-12
: - Drug: Gemcitabine
- Drug: liposomal doxorubi
|
| Completed |
: Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse
: - Ovarian Cancer
- Fallopian Tube Cancer
- Malignant Tumor of Pe
: 2005-09-12
: - Drug: Paclitaxel
- Drug: Topotecan
|
| Completed |
: Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients
: - Ovarian Cancer
- Fallopian Tube Neoplasms
- Peritoneal Neoplas
: 2005-09-12
: Biological: anti-EpCAM x anti-CD3 (removab)
|
| Completed |
: Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma
: - Ovarian Carcinoma
- Peritoneal Neoplasms
: 2005-09-09
: Drug: Docetaxel and Gemcitabine Docetaxel 75 mg/m2 IV over 15-30 minutes on day 1 followed by Gemcitabin
|
| Completed |
: Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
: - Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Ca
: 2005-08-29
: - Drug: carboplatin
- Drug: docetaxel
|
| Completed |
: Vorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
: - Primary Peritoneal Cavity Cancer
- Recurrent Ovarian Epithelial Cancer
: 2005-08-16
: Drug: vorinostat Given orally Other Names:
|
| Completed |
: Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
: - Fallopian Tube Cancer
- Primary Peritoneal Cavity Cancer
- Rec
: 2005-08-02
: - Biological: bevacizumab Given
|
